Following the recently released results from CLINUVEL’s CUV151 and CUV156 studies, CLINUVEL’s genomic expert, Dr Jessica Nucci, explains how DNA damage can increase the risk of cancer, and shares how melanocortins can help patients with xeroderma pigmentosum to mitigate this risk, as well as the next steps in the Company’s DNA Repair Program. 

Stay up to date on our DNA Repair Program: [ Ссылка ]

Read the technical note accompanying the CUV156 announcement: [ Ссылка ]

свернуть